Purification, crystallization and preliminary X-ray analysis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase of Streptococcus pneumoniae

被引:2
作者
Zhang, Liping [2 ]
Feng, Lingling [1 ,3 ]
Zhou, Li [1 ]
Gui, Jie [1 ]
Wan, Jian [1 ]
Hu, Xiaopeng [2 ]
机构
[1] Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol CCNU, Wuhan 430079, Peoples R China
[2] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
[3] Chinese Acad Sci, S China Inst Bot, Guangzhou 510650, Guangdong, Peoples R China
来源
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS | 2010年 / 66卷
基金
高等学校博士学科点专项科研基金;
关键词
3-hydroxy-3-methylglutaryl-coenzyme A reductases; Streptococcus pneumoniae; HMG-COA REDUCTASE; CRYSTAL-STRUCTURE; INHIBITION; MECHANISM;
D O I
10.1107/S1744309110036481
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Class II 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductases are potential targets for novel antibiotic development. In order to obtain a precise structural model for use in virtual screening and inhibitor design, HMG-CoA reductase of Streptococcus pneumoniae was cloned, overexpressed and purified to homogeneity using Ni-NTA affinity chromatography. Crystals were obtained using the hanging-drop vapour-diffusion method. A complete data set was collected from a single frozen crystal on a home X-ray source. The crystal diffracted to 2.3 A resolution and belonged to the orthorhombic space group C222(1), with unit-cell parameters a = 773.4836, b = 90.3055, c = 160.5592 A, alpha = beta = gamma = 90 degrees. Assuming the presence of two molecules in the asymmetric unit, the solvent content was estimated to be 54.1% (V (M) = 2.68 A3 Da-1).
引用
收藏
页码:1500 / 1502
页数:3
相关论文
共 18 条
  • [1] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [2] Sequence comparisons reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme A reductase
    Bochar, DA
    Stauffacher, CV
    Rodwell, VW
    [J]. MOLECULAR GENETICS AND METABOLISM, 1999, 66 (02) : 122 - 127
  • [3] PHARMACOLOGY OF COMPETITIVE INHIBITORS OF HMG-COA REDUCTASE
    CORSINI, A
    MAGGI, FM
    CATAPANO, AL
    [J]. PHARMACOLOGICAL RESEARCH, 1995, 31 (01) : 9 - 27
  • [4] Eisenberg Daniel A., 1998, American Journal of Medicine, V104, p2S, DOI 10.1016/S0002-9343(98)00038-2
  • [5] Coot:: model-building tools for molecular graphics
    Emsley, P
    Cowtan, K
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 : 2126 - 2132
  • [6] GOURLEY DG, 2003, 43 INT C ANT AG CHEM
  • [7] Cholesterol lowering with statin drugs, risk of stroke, and total mortality - An overview of randomized trials
    Hebert, PR
    Gaziano, JM
    Chan, KS
    Hennekens, CH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (04): : 313 - 321
  • [8] Inhibition of the Class II HMG-CoA reductase of Pseudomonas mevalonii
    Hedl, M
    Rodwell, VW
    [J]. PROTEIN SCIENCE, 2004, 13 (06) : 1693 - 1697
  • [9] Class II 3-hydroxy-3-methylglutaryl coenzyme a reductases
    Hedl, M
    Tabernero, L
    Stauffacher, CV
    Rodwell, VW
    [J]. JOURNAL OF BACTERIOLOGY, 2004, 186 (07) : 1927 - 1932
  • [10] Bacterial and mammalian HMG-CoA reductases: related enzymes with distinct architectures
    Istvan, ES
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2001, 11 (06) : 746 - 751